Trilliome
PrivateLast Round
Accelerator
Nov 18, 2025
Total Funding Raised
$378,000
Company Overview
Trilliome is a biotechnology company developing plant-derived, clinically validated ingredients that precisely modulate keystone gut microbial networks and their metabolites to target hallmarks of aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Circular Economy
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trilliome Comps
Public and private peers based on sector, stage, and business model.
Trilliome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 18, 2025 | ||||
| Grant | Oct 17, 2025 | ||||
| Grant | Feb 19, 2025 | ||||
| Grant | Nov 19, 2024 |
Key People
Founding team and executive leadership
Trilliome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotope by VIB | Accelerator |
| EIT Food | Grant |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
$270K raised from Biotope by VIB
- Oct 17, 2025
$53K grant received from EIT Food.
Trilliome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trilliome's valuation, stock price, and market status.
